Fadrowski JJ, Pierce CB, Cole SR, Moxey-Mims M, Warady BA, Furth SL (2008) Hemoglobin decline in children with chronic kidney disease: baseline results from the chronic kidney disease in children prospective cohort study. Clin J Am Soc Nephrol 3:457–462

Article  CAS  PubMed  PubMed Central  Google Scholar 

Koshy SM, Geary DF (2008) Anemia in children with chronic kidney disease. Pediatr Nephrol 23:209–219

Article  PubMed  Google Scholar 

Akchurin O, Molino AR, Schneider MF, Atkinson MA, Warady BA, Furth SL (2023) Longitudinal relationship between anemia and statural growth impairment in children and adolescents with nonglomerular CKD: findings from the Chronic Kidney Disease in Children (CKiD) study. Am J Kidney Dis 81:457-465.e1

Article  PubMed  Google Scholar 

Ganz T, Nemeth E (2016) Iron balance and the role of hepcidin in chronic kidney disease. Semin Nephrol 36:87–93

Article  CAS  PubMed  PubMed Central  Google Scholar 

Atkinson MA, Kim JY, Roy CN, Warady BA, White CT, Furth SL (2015) Hepcidin and risk of anemia in CKD: a cross-sectional and longitudinal analysis in the CKiD cohort. Pediatr Nephrol 30:635–643

Article  PubMed  Google Scholar 

McMurray J, Parfrey P, Adamson JW, Aljama P, Berns JS, Bohlius J, Drüeke TB, Finkelstein FO, Fishbane S, Ganz T (2012) Kidney disease: improving global outcomes (KDIGO) anemia work group. KDIGO clinical practice guideline for anemia in chronic kidney disease. Kidney Int Suppl :279–335

Patino E, Akchurin O (2022) Erythropoiesis-independent effects of iron in chronic kidney disease. Pediatr Nephrol 37:777–788

Article  PubMed  Google Scholar 

Akchurin OM, Schneider MF, Mulqueen L, Brooks ER, Langman CB, Greenbaum LA, Furth SL, Moxey-Mims M, Warady BA, Kaskel FJ, Skversky AL (2014) Medication adherence and growth in children with CKD. Clin J Am Soc Nephrol 9:1519–1525

Article  PubMed  PubMed Central  Google Scholar 

Babitt JL, Eisenga MF, Haase VH, Kshirsagar AV, Levin A, Locatelli F, Małyszko J, Swinkels DW, Tarng D-C, Cheung M (2021) Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference. Kidney Int 99:1280–1295

Article  PubMed  Google Scholar 

Hollowell JG, van Assendelft OW, Gunter EW, Lewis BG, Najjar M, Pfeiffer C (2005) Hematological and iron-related analytes–reference data for persons aged 1 year and over: United States, 1988–94. Vital Health Stat 11:1–156

Google Scholar 

Schwartz GJ, Munoz A, Schneider MF, Mak RH, Kaskel F, Warady BA, Furth SL (2009) New equations to estimate GFR in children with CKD. J Am Soc Nephrol 20:629–637

Article  PubMed  PubMed Central  Google Scholar 

Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Tonelli M, Garg AX, Pellegrini F, Ravani P, Jardine M, Perkovic V (2010) Meta-analysis: erythropoiesis-stimulating agents in patients with chronic kidney disease. Ann Intern Med 153:23–33

Article  PubMed  Google Scholar 

Rheault MN, Molony JT, Nevins T, Herzog CA, Chavers BM (2017) Hemoglobin of 12 g/dl and above is not associated with increased cardiovascular morbidity in children on hemodialysis. Kidney Int 91:177–182

Article  CAS  PubMed  Google Scholar 

Akchurin OM (2019) Chronic kidney disease and dietary measures to improve outcomes. Pediatr Clin North Am 66:247–267

Article  PubMed  PubMed Central  Google Scholar 

Akchurin O, Sureshbabu A, Doty SB, Zhu YS, Patino E, Cunningham-Rundles S, Choi ME, Boskey A, Rivella S (2016) Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease. Am J Physiol Renal Physiol 311:F877–F889

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wheby MS (1980) Effect of iron therapy on serum ferritin levels in iron-deficiency anemia. Blood 56:138–140

Article  CAS  PubMed  Google Scholar 

Prentice AM, Doherty CP, Abrams SA, Cox SE, Atkinson SH, Verhoef H, Armitage AE, Drakesmith H (2012) Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood 119:1922–1928

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moretti D, Goede JS, Zeder C, Jiskra M, Chatzinakou V, Tjalsma H, Melse-Boonstra A, Brittenham G, Swinkels DW, Zimmermann MB (2015) Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood 126:1981–1989

Article  CAS  PubMed  Google Scholar 

Patino E, Bhatia D, Vance SZ, Antypiuk A, Uni R, Campbell C, Castillo CG, Jaouni S, Vinchi F, Choi ME, Akchurin O (2022) Iron therapy mitigates chronic kidney disease progression by regulating intracellular iron status of kidney macrophages. JCI insight 8:e159235

Article  Google Scholar 

Okam MM, Koch TA, Tran M-H (2017) Iron supplementation, response in iron-deficiency anemia: analysis of five trials. Am J Med 130:991-e991

Article  Google Scholar 

Van Wyck DB, Roppolo M, Martinez CO, Mazey RM, McMurray S (2005) A randomized, controlled trial comparing IV iron sucrose to oral iron in anemic patients with nondialysis-dependent CKD. Kidney Int 68:2846–2856

Article  PubMed  Google Scholar 

Macdougall IC, Bock AH, Carrera F, Eckardt K-U, Gaillard C, Van Wyck D, Roubert B, Nolen JG, Roger SD (2014) FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrol Dial Transplant 29:2075–2084

Article  CAS  PubMed  PubMed Central  Google Scholar 

Spinowitz BS, Kausz AT, Baptista J, Noble SD, Sothinathan R, Bernardo MV, Brenner L, Pereira BJG (2008) Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol 19:1599–1605

Article  CAS  PubMed  PubMed Central  Google Scholar 

Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL (2017) Effect of low-dose ferrous sulfate vs iron polysaccharide complex on hemoglobin concentration in young children with nutritional iron-deficiency anemia: a randomized clinical trial. JAMA 317:2297–2304

Article  CAS  PubMed  PubMed Central  Google Scholar 

Guedes M, Muenz DG, Zee J, Bieber B, Stengel B, Massy ZA, Mansencal N, Wong MMY, Charytan DM, Reichel H (2021) Serum biomarkers of iron stores are associated with increased risk of all-cause mortality and cardiovascular events in nondialysis CKD patients, with or without anemia. J Am Soc Nephrol 32:2020–2030

Article  CAS  PubMed  PubMed Central  Google Scholar 

Patino E, Doty SB, Bhatia D, Meza K, Zhu YS, Rivella S, Choi ME, Akchurin O (2020) Carbonyl iron and iron dextran therapies cause adverse effects on bone health in juveniles with chronic kidney disease. Kidney Int 98:1210–1224

Article  CAS  PubMed  PubMed Central  Google Scholar 

Akchurin O, Patino E, Dalal V, Meza K, Bhatia D, Brovender S, Zhu YS, Cunningham-Rundles S, Perelstein E, Kumar J, Rivella S, Choi ME (2019) Interleukin-6 contributes to the development of anemia in juvenile CKD. Kidney Int Rep 4:470–483

Article  PubMed  Google Scholar 

Kalra PA, Bhandari S, Saxena S, Agarwal D, Wirtz G, Kletzmayr J, Thomsen LL, Coyne DW (2016) A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia. Nephrol Dial Transplant 31:646–655

Article  CAS  PubMed  Google Scholar 

Womack R, Berru F, Panwar B, Gutiérrez OM (2020) Effect of ferric citrate versus ferrous sulfate on iron and phosphate parameters in patients with iron deficiency and CKD: a randomized trial. Clin J Am Soc Nephrol 15:1251–1258

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warady BA, Kausz A, Lerner G, Brewer ED, Chadha V, Brugnara C, Dahl NV, Watkins SL (2004) Iron therapy in the pediatric hemodialysis population. Pediatr Nephrol 19:655–661

Article  PubMed  Google Scholar 

Atkinson MA, Pierce CB, Fadrowski JJ, Benador NM, White CT, Turman MA, Pan CG, Abraham AG, Warady BA, Furth SL (2012) Association between common iron store markers and hemoglobin in children with chronic kidney disease. Pediatr Nephrol 27:2275–2283

Article  PubMed  PubMed Central  Google Scholar 

Prats M, Font R, García C, Muñoz-Cortés M, Cabré C, Jariod M, Romeu M, Giralt M, Martinez-Vea A (2014) Oxidative stress markers in predicting response to treatment with ferric carboxymaltose in nondialysis chronic kidney disease patients. Clin Nephrol 81:419–426

Article  CAS  PubMed  Google Scholar 

Macdougall IC, Bock AH, Carrera F, Eckardt K-U, Gaillard C, Van Wyck D, Meier Y, Larroque S, Perrin A, Roger SD (2017) Erythropoietic response to oral iron in patients with nondialysis-dependent chronic kidney disease in the FIND-CKD trial. Clin Nephrol 88:301

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gaillard CA, Bock AH, Carrera F, Eckardt K-U, Van Wyck DB, Bansal SS, Cronin M, Meier Y, Larroque S, Roger SD (2016) Hepcidin response to iron therapy in patients with non-dialysis dependent CKD: an analysis of the FIND-CKD trial. PLoS One 11:e0157063

Article  PubMed  PubMed Central  Google Scholar 

Stancu S, Bârsan L, Stanciu A, Mircescu G (2010) Can the response to iron therapy be predicted in anemic nondialysis patients with chronic kidney disease? Clin J Am Soc Nephrol 5:409–416

Article  CAS  PubMed  PubMed Central  Google Scholar 

Takasawa K, Takaeda C, Wada T, Ueda N (2018) Optimal serum ferritin levels for iron deficiency anemia during oral iron therapy (